Harvard Bioscience (HBIO) Short Interest
Nasdaq • HBIO • US4169062043
As of Oct 28, 2026, ORTEX estimated 1.4% of free float sold short, 3.3 days to cover, cost to borrow 0.62%. Sign up for live short interest data.
Nasdaq • HBIO • US4169062043
As of Oct 28, 2026, ORTEX estimated 1.4% of free float sold short, 3.3 days to cover, cost to borrow 0.62%. Sign up for live short interest data.
This page tracks how heavily Harvard Bioscience (Nasdaq:HBIO) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Harvard Bioscience (Nasdaq: HBIO) has a market capitalization of $44.66M. Last close $9.68 (as of 2026-11-12); 52-week range $4.00 to $10.20. ORTEX data as of 2026-10-28: short interest was 1.4% of free float, 3.3 days to cover and the average cost to borrow was 0.62%. Sign up for live short interest data.